Literature DB >> 23825751

Elevated high-sensitivity C-reactive protein in preterm infants with pulmonary colonization with Ureaplasma.

John T Meadows1, Benjamin T Kopp, Lori A Shook, Hubert O Ballard, Don Hayes.   

Abstract

BACKGROUND: A link between pulmonary Ureaplasma spp. colonization in premature infants and bronchopulmonary dysplasia (BPD) exists and could possibly contribute to systemic inflammation.
METHODS: A prospective cohort study was performed from July 2006 to July 2007 where very low birth weight (VLBW) premature infants were screened at birth. Serum and tracheal aspirate samples were collected during the first 28 days of life that represented the early high-sensitivity C-reactive protein (hs-CRP) group, and follow-up samples obtained between 28-42 days of life were the late hs-CRP group. An Enzyme-linked immunosorbent assay (ELISA) for hs-CRP was performed on serum samples while tracheal aspirates underwent polymerase chain reaction (PCR) analysis for Ureaplasma spp.
RESULTS: A total of 65 patients were screened. 30 patients completed full analysis, 15 died before early and late hs-CRP samples could be obtained, and 20 had incomplete data due to early discharge or transfer. There was no significant difference between all early and late hs-CRP group levels (mg/L), median [interquartile range] 1.019 [0.242, 5.844] vs. 0.773 [0.143, 8.954] (P=0.3958); however, there was a significant difference when comparing Ureaplasma spp. positivity vs. negativity between both groups, median 2.223 [0.398, 7.099] vs. 0.675 [0.219, 4.038] (P=0.0131) for the early group and median 2.335 [0.359, 14.91] vs. 0.2155 [0.122, 2.296] (P=0.03) for the late group, respectively.
CONCLUSIONS: VLBW premature infants colonized with Ureaplasma spp. have an elevated hs-CRP, suggestive of a chronic low-grade systemic inflammatory response.

Entities:  

Keywords:  High-sensitivity C-reactive protein (hs-CRP); Ureaplasma; bronchopulmonary dysplasia (BPD); preterm infant

Year:  2013        PMID: 23825751      PMCID: PMC3698281          DOI: 10.3978/j.issn.2072-1439.2013.04.14

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  24 in total

Review 1.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.

Authors:  Sotirios Tsimikas; James T Willerson; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2006-04-18       Impact factor: 24.094

Review 2.  C-reactive protein: a nontraditional serum marker of cardiovascular risk.

Authors:  Sarah D de Ferranti; Nader Rifai
Journal:  Cardiovasc Pathol       Date:  2007 Jan-Feb       Impact factor: 2.185

3.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

4.  High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry.

Authors:  T E Deraz; Terez B Kamel; Tahany A El-Kerdany; Heba M A El-Ghazoly
Journal:  Pediatr Pulmonol       Date:  2011-09-29

5.  Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease.

Authors:  S Kotecha; B Chan; N Azam; M Silverman; R J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

6.  High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.

Authors:  Sergio Raposeiras Roubín; Cristina Barreiro Pardal; Filomena Roubín-Camiña; Raymundo Ocaranza Sanchez; Ezequiel Alvarez Castro; Beatriz Paradela Dobarro; Jose María García-Acuña; Pablo Aguiar Souto; Michel Jacquet Hervet; Maria José Castromán; Isabel Arufe; Belén Outes; María Victoria Reino-Maceiras; Emad Abu Assi; José Ramón González-Juanatey
Journal:  Rev Port Cardiol       Date:  2013-01-20       Impact factor: 1.374

7.  Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors.

Authors:  Tarah T Colaizy; Cynthia D Morris; Jodi Lapidus; Ronald S Sklar; De-Ann M Pillers
Journal:  Pediatr Res       Date:  2007-05       Impact factor: 3.756

8.  High-sensitivity C-reactive protein levels and cancer mortality.

Authors:  Young-Jin Ko; Young-Min Kwon; Kyae Hyung Kim; Ho-Chun Choi; So Hyun Chun; Hyung-Jin Yoon; Eurah Goh; Belong Cho; Minseon Park
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11       Impact factor: 4.254

Review 9.  Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Authors:  Rose Marie Viscardi; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

10.  Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.

Authors:  Namasivayam Ambalavanan; Waldemar A Carlo; Carl T D'Angio; Scott A McDonald; Abhik Das; Diana Schendel; Poul Thorsen; Rosemary D Higgins
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.